A Phase 1, Randomized, Double-Blind, Placebo- and Active-Controlled Crossover Study to Evaluate the Effect of Repeat Oral Doses of ASP1941 on Cardiac Repolarization in Healthy Male and Female Adult Subjects.

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo- and Active-Controlled Crossover Study to Evaluate the Effect of Repeat Oral Doses of ASP1941 on Cardiac Repolarization in Healthy Male and Female Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Ipragliflozin (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 25 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2010 Planned end date changed from Dec 2010 to Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top